The earnings call highlighted strong international growth and product innovation as key positive aspects. However, domestic revenue challenges, margin pressures, and regulatory uncertainties present significant challenges. The call reflects a balanced outlook with robust international performance countered by domestic and regulatory pressures.

Company Guidance

During the Curaleaf Holdings Second Quarter 2025 Conference Call, the company reported revenue of $315 million, reflecting a 1.5% increase from the first quarter, aligning with their guidance for low single-digit growth. The International segment was a highlight, showing a 17% sequential increase in revenue. Adjusted gross margin was reported at 49%, down by 130 basis points from the first quarter due to increased promotional activity. The company achieved $66 million in adjusted EBITDA, resulting in a 21% AEBITDA margin. Curaleaf's cash position stood at $102 million, after making $47 million in interest and principal debt payments, while generating $9 million in operating cash flow. The company also highlighted their strategic focus on product innovation and international expansion, including a notable presence in Germany and the receipt of a license to enter Turkey.

International Segment Growth

Curaleaf's International segment reported a 17% sequential growth in revenue and a 62% year-over-year increase, driven by strong demand in Germany and the U.K.

Product Innovation Success

Curaleaf launched several new products, including the ACE and Anthem lines, which have received strong market reception and are expected to drive future growth.

Strategic International Expansion

Curaleaf completed the buyout of its minority partner in Curaleaf International and received a license to enter Turkey, positioning it for significant growth in new markets.

Improved Cultivation Practices

The company has made significant improvements in its cultivation practices, leading to high-quality flower production and improved genetics.

Strong R&D and Brand Leadership

Curaleaf continues to lead with its Select brand being the #1 vape brand in the U.S. and Grassroots being a top 3 flower brand.

Curaleaf Holdings (TSE:CURA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:CURA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	-0.10 / -	-0.097	―	―	―
Aug 06, 2025	2025 (Q2)	-0.08 / -0.08	-0.083	0.00% (0.00)	―
May 08, 2025	2025 (Q1)	-0.09 / -0.10	-0.097	0.00% (0.00)	―
Mar 03, 2025	2024 (Q4)	-0.09 / -0.14	-0.11	-25.00% (-0.03)	―
Nov 06, 2024	2024 (Q3)	-0.09 / -0.10	-0.124	22.22% (+0.03)	―
Aug 07, 2024	2024 (Q2)	-0.08 / -0.08	-0.124	33.33% (+0.04)	―
May 09, 2024	2024 (Q1)	-0.08 / -0.10	-0.069	-40.00% (-0.03)	―
Mar 06, 2024	2023 (Q4)	-0.07 / -0.11	-0.497	77.78% (+0.39)	―
Nov 09, 2023	2023 (Q3)	-0.09 / -0.12	-0.097	-28.57% (-0.03)	―
Aug 09, 2023	2023 (Q2)	-0.06 / -0.12	-0.055	-125.00% (-0.07)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:CURA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 06, 2025	C$2.31	C$2.41	+4.33%
May 08, 2025	C$1.21	C$1.14	-5.79%
Mar 03, 2025	C$1.75	C$1.52	-13.14%
Nov 06, 2024	C$3.04	C$3.09	+1.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Curaleaf Holdings (TSE:CURA) report earnings?

Curaleaf Holdings (TSE:CURA) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).

What is Curaleaf Holdings (TSE:CURA) earnings time?

Curaleaf Holdings (TSE:CURA) earnings time is at Nov 10, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:CURA EPS forecast?

TSE:CURA EPS forecast for the fiscal quarter 2025 (Q3) is -0.1.

Curaleaf Holdings (TSE:CURA) Earnings News

Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here

Premium

Market News

Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here

3y ago

See More TSE:CURA News >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing